About preCARDIA
preCARDIA is a company based in Saint Paul (United States) founded in 2016 was acquired by Abiomed in June 2021. It operates as a HealthTech. preCARDIA offers products and services including preCARDIA System. preCARDIA operates in a competitive market with competitors including Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
- Headquarter Saint Paul, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of preCARDIA
preCARDIA offers a comprehensive portfolio of products and services, including preCARDIA System.
Designed to treat acute decompensated heart failure effectively.
Funding Insights of preCARDIA
Detailed funding history for preCARDIA
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in preCARDIA
preCARDIA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abiomed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Heart pumps are developed for blood circulation and oxygenation support.
|
Locked | Locked | Locked |
Investor details for preCARDIA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by preCARDIA
Investment portfolio details for preCARDIA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - preCARDIA
Detailed financials for preCARDIA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precardia Comparisons
Peer comparison for preCARDIA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of preCARDIA
preCARDIA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Miniaturized ventricular assist devices are developed for heart failure treatment.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
|
| Locked | Locked | Locked |
Total artificial hearts are developed for cardiac replacement therapy.
|
Detailed competitors of preCARDIA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precardia
Complete news archive for preCARDIA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about preCARDIA
preCARDIA was founded in 2016.
preCARDIA is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Lisa Wipperman Heine is the current CEO of preCARDIA.
preCARDIA is engaged in developing innovative medical devices aimed at treating acute decompensated heart failure (ADHF). The companys proprietary catheter and controller system is designed to reduce cardiac filling pressures and promote decongestion, improving cardiac and renal function. Solutions are targeted at heart failure specialists to provide minimally invasive interventions. The technology addresses a critical need in healthcare by offering potential reductions in hospital stays and re-hospitalizations for ADHF patients. Operations are centered in the healthcare sector with a focus on cardiovascular care.
preCARDIA's top competitors include Sequana Medical, CVRx and Adona Medical.
preCARDIA offers preCARDIA System.
preCARDIA has 1 investor. Key investors include Abiomed.